awmsg logo



tinzaparin sodium (Innohep®)


Reference No. 2369

Publication date:
10/12/2015


Appraisal information

tinzaparin sodium (Innohep®) 20,000 units/ml solution for injection


Company: LEO Pharma
BNF category: Cardiovascular system
NMG meeting date: 07/10/2015
AWMSG meeting date: 11/11/2015
   
   
Submission Type: Limited Submission
Status: Recommended
Advice No: 3715
Ministerial ratification: 09/12/2015

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

Tinzaparin sodium (innohep® Syringe) is recommended as an option for use within NHS Wales for the extended treatment of symptomatic venous thromboembolism and prevention of its recurrence in adult patients with solid tumours.
Final Appraisal Recommendation (FAR)
Download
AWMSG Secretariat Appraisal Report (ASAR)
Download
Clinical Expert (CE) Summary
Download